Literature DB >> 17481953

A two-signal model for T cell trafficking.

Federica M Marelli-Berg1, Klaus Okkenhaug, Vincenzo Mirenda.   

Abstract

T-cell-receptor triggering and the delivery of co-stimulation are essential events leading to T cell expansion, differentiation and effector function. The influence that such signals exert on T cell migration during and following priming has been highlighted by recent reports. Moreover, induction of peripheral tolerance might act in part by affecting T cell migration. Here, we propose that the integration of co-stimulatory signals, which regulate the ability of primed T cells to access nonlymphoid tissue, and cognate recognition of the endothelium, which determines the selective recruitment of specific T cells, contribute to the anatomy of T cell-mediated immunity and tolerance. The implications for therapeutic strategies manipulating these signals are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17481953     DOI: 10.1016/j.it.2007.04.008

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  18 in total

1.  An Endothelial Planar Cell Model for Imaging Immunological Synapse Dynamics.

Authors:  Roberta Martinelli; Christopher V Carman
Journal:  J Vis Exp       Date:  2015-12-24       Impact factor: 1.355

2.  Antigen recognition is facilitated by invadosome-like protrusions formed by memory/effector T cells.

Authors:  Peter T Sage; Laya M Varghese; Roberta Martinelli; Tracey E Sciuto; Masataka Kamei; Ann M Dvorak; Timothy A Springer; Arlene H Sharpe; Christopher V Carman
Journal:  J Immunol       Date:  2012-03-21       Impact factor: 5.422

3.  Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.

Authors:  Tihamer Orban; Brian Bundy; Dorothy J Becker; Linda A DiMeglio; Stephen E Gitelman; Robin Goland; Peter A Gottlieb; Carla J Greenbaum; Jennifer B Marks; Roshanak Monzavi; Antoinette Moran; Philip Raskin; Henry Rodriguez; William E Russell; Desmond Schatz; Diane Wherrett; Darrell M Wilson; Jeffrey P Krischer; Jay S Skyler
Journal:  Lancet       Date:  2011-06-28       Impact factor: 79.321

4.  OX40 induces CCL20 expression in the context of antigen stimulation: an expanding role of co-stimulatory molecules in chemotaxis.

Authors:  Wenwei Zhong; Zili Zhang; David Hinrichs; Xiumei Wu; Mark Hall; Zhenwei Xia; James T Rosenbaum
Journal:  Cytokine       Date:  2010-04-18       Impact factor: 3.861

5.  Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity.

Authors:  Nitya Jain; Hai Nguyen; Cynthia Chambers; Joonsoo Kang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

6.  Lactobacillus plantarum prevents the upregulation of adhesion molecule expression in an experimental colitis model.

Authors:  Zhao-Xin Chu; Hong-Qi Chen; Yan-Lei Ma; Yu-Kun Zhou; Ming Zhang; Peng Zhang; Huan-Long Qin
Journal:  Dig Dis Sci       Date:  2009-12-04       Impact factor: 3.199

7.  T cells require Foxo1 to populate the peripheral lymphoid organs.

Authors:  Melanie R Gubbels Bupp; Bonnie Edwards; Caiying Guo; Datsen Wei; Gang Chen; Brian Wong; Emma Masteller; Stanford L Peng
Journal:  Eur J Immunol       Date:  2009-11       Impact factor: 5.532

8.  T-cell receptor- and CD28-induced Vav1 activity is required for the accumulation of primed T cells into antigenic tissue.

Authors:  Rachel David; Liang Ma; Aleksandar Ivetic; Aya Takesono; Anne J Ridley; Jian-Guo Chai; Victor L Tybulewicz; Federica M Marelli-Berg
Journal:  Blood       Date:  2008-12-05       Impact factor: 22.113

9.  Regulatory T-cell neutralization in mice during filariasis helps in parasite clearance by enhancing T helper type 17-mediated pro-inflammatory response.

Authors:  Manisha Pathak; Pankaj Sharma; Aditi Sharma; Meenakshi Verma; Mrigank Srivastava; Shailja Misra-Bhattacharya
Journal:  Immunology       Date:  2015-12-09       Impact factor: 7.397

10.  Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.

Authors:  Jay S Skyler; Alberto Pugliese
Journal:  Diabetes Technol Ther       Date:  2013-06       Impact factor: 6.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.